Tinea Infection
Key Points
- Tinea infection is a superficial fungal infection of skin, hair, or nails with body-site-specific subtypes.
- Most tinea syndromes are caused by dermatophytes, while tinea versicolor is caused by Malassezia and is not considered contagious.
- Common subtype patterns are capitis (scalp), corporis (trunk/extremities), cruris (groin), pedis (feet), and versicolor (pigment-shift lesions).
- Nursing priorities are early pattern recognition, secondary bacterial-infection surveillance, antifungal adherence, and reinfection prevention teaching.
Pathophysiology
Dermatophyte tinea infections develop when fungal organisms attach to and proliferate in keratinized tissue (skin, hair, nails). Spread can occur by direct skin contact, contaminated objects, and selected environmental exposures such as communal wet areas.
Tinea capitis involves hair-follicle invasion, while tinea corporis and cruris usually involve superficial keratinized skin. Tinea pedis commonly begins in moist toe-web spaces and may extend to nails (onychomycosis). Self-inoculation between body regions can occur.
Tinea versicolor differs mechanistically from dermatophyte infection. It is associated with Malassezia overgrowth on skin flora background and causes variable pigment changes; it is generally managed as a noncontagious process.
Classification
- Tinea capitis: Scalp lesions with erythematous or scaly borders, pruritus, and patchy hair loss.
- Tinea corporis: Pruritic annular or oval lesions with scaly erythematous border and relative central clearing.
- Tinea cruris: Erythematous scaly pruritic rash of groin/perineal folds with raised lesion margins.
- Tinea pedis: Toe or foot lesions with scale, peeling, fissures, and pruritus; chronic moisture exposure is a common contributor.
- Tinea versicolor: Multiple fine scaly lesions with hypo- or hyperpigmented appearance, often on trunk and upper extremities.
Nursing Assessment
NCLEX Focus
Identify the subtype pattern first, then assess spread risk, comfort impact, and signs of secondary bacterial infection.
- Assess lesion morphology, body-site distribution, pruritus burden, and progression over time.
- In tinea capitis, assess scalp inflammation and alopecia distribution, including concern for severe inflammatory plaques.
- In tinea pedis, assess maceration, fissuring, and interdigital skin breakdown that can predispose to bacterial superinfection.
- In tinea cruris, assess clothing/friction/moisture contributors and whether rash pattern remains localized versus spreading.
- In tinea versicolor, assess pigment variation pattern and psychosocial distress related to cosmetic change.
- Assess for secondary bacterial-infection cues: increasing erythema, warmth, edema, purulent drainage, or systemic symptoms.
- Assess reinfection risks: tight nonbreathable clothing, prolonged wet footwear, communal barefoot exposure, and shared personal items.
Diagnostics
- Diagnosis is often clinical from lesion pattern and distribution.
- Skin scraping microscopy and fungal culture can support confirmation when diagnosis is uncertain.
- Wood-lamp support may assist selected capitis and versicolor presentations.
Nursing Interventions
- Administer prescribed antifungal therapy and reinforce adherence through full treatment duration.
- Support hygiene and moisture-control routines: keep skin folds and toe webs dry and use breathable clothing/footwear.
- Encourage moisture-wicking socks and avoidance of prolonged enclosed nonbreathable shoes for recurrent pedis patterns.
- Teach use of sandals or shower footwear in communal wet environments.
- Reinforce nonsharing of towels, clothing, combs, and hairbrushes to reduce cross-transmission and reinoculation.
- Escalate persistent, recurrent, or treatment-resistant infection for dermatology or infectious-disease referral per protocol.
- For tinea capitis, reinforce that oral therapy is typically required and topical agents alone are not curative.
- Monitor and report secondary bacterial-infection progression promptly.
Recurrence Risk
Incomplete treatment and poor moisture or fomite control can lead to recurrent infection and spread to other body sites.
Pharmacology
| Drug Class | Examples | Key Nursing Considerations |
|---|---|---|
| antifungal-medications | Topical azoles and allylamines; oral antifungals for selected indications | Tinea capitis generally requires oral therapy; monitor for adverse effects and needed lab follow-up with systemic agents. |
| antibiotics | Secondary skin-infection treatment contexts | Used when fungal lesions become secondarily infected by bacteria. |
Clinical Judgment Application
Clinical Scenario
A school-age child presents with pruritic scalp patches and localized hair loss; a sibling has scaling toe-web lesions after frequent pool use.
- Recognize Cues: Distinct tinea subtype patterns across body sites plus household exposure context.
- Analyze Cues: Findings support likely capitis in one client and pedis pattern in another, with reinfection risk in shared environment.
- Prioritize Hypotheses: Treat active infection, prevent spread, and reduce recurrence through hygiene/moisture interventions.
- Generate Solutions: Start ordered antifungal plans, reinforce capitis oral-therapy expectation, and implement household prevention teaching.
- Take Action: Assess for bacterial superinfection, teach footwear/laundry/nonsharing measures, and coordinate follow-up.
- Evaluate Outcomes: Lesions improve, pruritus decreases, and no new household cases occur.
Related Concepts
- infectious-and-inflammatory-skin-conditions - Pattern-level triage across fungal, bacterial, viral, and parasitic lesions.
- antifungal-medications - Drug classes, adverse effects, and monitoring for topical and systemic therapy.
- integumentary-system - Barrier integrity and moisture/friction factors that influence fungal infection risk.
- impetigo - Secondary bacterial skin-infection differential when lesions become crusted or purulent.
Self-Check
- Which findings help distinguish tinea capitis, corporis, cruris, pedis, and versicolor?
- Why is oral therapy usually required for tinea capitis?
- Which household and lifestyle measures most reduce recurrence and self-inoculation risk?